FOS and breast carcinoma: The overall survival data showed that the prognosis of breast cancer patients was poorer when two genes (FOS and FOSB) were highly expressed or when four genes (JUN, GADD45B, NR4A1, and BTG2) showed low expression levels (Supplementary Figure 4B).